iSatori, trading on the OTC Markets under the ticker IFIT, is a developer and marketer of nutraceutical and wellness products designed to support weight management, performance enhancement, and overall health. The company’s product lineup features thermogenic fat burners, appetite regulators, targeted nutritional formulas and plant-based protein blends. Emphasizing a science-backed approach, iSatori leverages clinical research and ingredient efficacy studies to formulate supplements that address specific health goals, from metabolic support to anti-aging benefits.
Distribution of iSatori’s products is conducted through a blend of direct-to-consumer e-commerce channels and a network marketing model. The company maintains a presence in key North American markets, including the United States and Canada, while also extending its reach into Latin America and select European territories. In addition to proprietary online platforms, iSatori partners with independent brand ambassadors who facilitate product education, customer engagement and community building, reinforcing the brand’s commitment to personalized wellness guidance.
Founded with a vision of integrating rigorous research with consumer-driven product development, iSatori operates manufacturing in cGMP-certified facilities to ensure quality and consistency. The leadership team comprises industry veterans in nutrition science, regulatory compliance and direct marketing, supported by an advisory board of clinical researchers. Through ongoing investment in formulation innovation and strategic market expansion, iSatori seeks to strengthen its position in the global dietary supplement sector while delivering tailored health solutions to its growing customer base.
AI Generated. May Contain Errors.
